VisualMED Clinical Solutions Looking To Make it Count

0
630

VisualMED Clinical Solutions Corp. recently saw a strong move up after the Company announced it will be adapting some of its tertiary care intelligent applications for patients to monitor their personal medical issues. VMCS is relying on its long-standing relationships with an academic world leader on the deployment of AI into useful applications.

VisualMED Clinical Solutions Corp. provides the complete electronic patient record. VisualMED obviates the need for redundant, paper-based activities by doctors and nurses. All patient care is prescribed and documented in an electronic media that may include wireless devices with remote access via an Internet portal. The computerized physician order entry (CPOE) module with more than 30 levels of decision support is an expert system with knowledge base and inference engine that validate information provided by the user according to algorithms the support the nuance of local practice.

VMCS initiative in using artificial intelligence in reformatting or applications has met with a significant measure of success in the past quarter. Some of its new R&D will be carried out with the support of new European partners. They are in the process of qualifying for new government grants thanks to its focus of making clinical tools available to patients to help manage their own health outcomes.

In April the Company announced a share exchange agreement has been signed for the return to the company of 230 million shares of Visual Healthcare Corp. common stock. The shares were initially issued to Ithaca Scientific Ventures, Inc. and were pledged as collateral on a loan to a third party. Mr. Gerard Dab, former CEO of Visual Healthcare Corp. and current CEO of VisualMED Clinical Solutions Corp., was instrumental in facilitating the transaction between the two parties. The company plans to cancel the shares once the transaction is complete.

For the inside scoop on VMCS enter your email address below

Sign Up now for our 100% FREE Penny Stock Newsletter

Mr. Linh Nguyen, CEO, states, “We would like to thank Mr. Dab for his cooperation and professionalism in bringing the two parties together and helping us reach a mutually-beneficial agreement. We are pleased to have been able to resolve this issue without a long, drawn out legal process while also reducing any risk of dilution to current shareholders.”

Details of the agreement will be released through OTC Markets once the transaction is finalized and all obligations of each party have been satisfied. With the retirement of these shares, Visual Healthcare Corp. will have approximately 311 million issued and outstanding shares of common stock. This equates to a reduction of approximately 43% of our current outstanding shares.

On June 5 VMCS announced it will be adapting some of its tertiary care intelligent applications for patients to monitor their personal medical issues. The company is relying on its long-standing relationships with an academic world leader on the deployment of AI into useful applications.

These new initiatives are also made possible by multibillion government programs designed to support Canadas and Montreal’s continuing leadership in artificial intelligence. The company is in the process of seeking public funding for its new initiatives. The company will soon begin to resume reporting and filing on OTC Markets. We also have reduced the number of shares issued and outstanding by more than 25% in this quarter and will continue our policy of OS reduction going forward.

Currently trading at a $5.7 million market valuation VMCS has a stop sign designation from OTC Markets, the Company has little assets, little debt and reported $600,000 in sales for the 2nd quarter, 2019 compared to $90k for the same period last year. VisualMED is an exciting story developing in small caps; VMCS initiative in using artificial intelligence in reformatting or applications has met with a significant measure of success in the past quarter.

For the inside scoop on VMCS enter your email address below

Sign Up now for our 100% FREE Penny Stock Newsletter

LEAVE A REPLY

Please enter your comment!
Please enter your name here